2m 2m 2m 2m 2m 2m 2m
Metagenomi Thera (MGX)
NASDAQ
$0.82-$0.01 (-1.42%)
Price as of Oct 22, 2026 7:08 PM EDT- $31.3MMarket Cap
- -71.22%1-Year Change
- BiotechnologyIndustry
Metagenomi Thera (MGX)
$0.82-$0.01 (-1.42%)
MGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.83 | ||
Change | -$0.003 (-0.30%) | ||
Open | $0.85 | ||
High | $0.86 | ||
Low | $0.80 | ||
Previous Close | $0.83 | ||
Volume | 85,775 | ||
30-Day Average Volume | 164,969 | ||
1-Week Change | -3.76% | ||
1-Month Change | -26.00% | ||
1-Year Change | -71.22% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 37.8M | ||
Total Assets | $173.7M | ||
Market Cap | $31.3M | ||
Enterprise Value | -$7.7M | ||
Period: QTR TTM FY | |||
Revenue | $80.0M | ||
Net Income | -$27.5M | ||
Free Cash Flow | -$19.6M | ||
EBIT | -$27.5M | ||
EBITDA | -$26.2M | ||
Net Working Capital | $96.8M | ||
EPS | -$0.73 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | -0 | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue